Karyopharm Therapeutics Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Karyopharm Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.26 USD/shares, a 13.3% increase year-over-year.
  • Karyopharm Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.79 USD/shares, a 39.7% increase year-over-year.
  • Karyopharm Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -1.25 USD/shares, a 38.1% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -2.02 USD/shares, a 22.4% decline from 2021.
  • Karyopharm Therapeutics Inc. annual Earnings Per Share, Basic for 2021 was -1.65 USD/shares, a 39.3% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1 $0 +$0.04 +13.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$1 $0.15 +$0.44 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$1 $0 $0 -6.67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$1 $0 +$0.06 +14.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$1 $0 +$0.15 +33.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$1 $0 +$0.33 +53.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$2 $0 +$0.23 +43.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$2 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $0 +$0.24 +34.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$1 +$0.09 +12.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.